VYNE Therapeutics Inc. deeply regrets to announced that Mr. Rex Bright passed away on January 11, 2022. Mr. Bright was a director of the company and also served as the Chair of the Company's Compensation Committee and a member of the Company's Audit Committee. On January 14, 2022, the Board appointed Patrick LePore to serve as a member of the Company's Audit Committee and Elisabeth Sandoval to serve as chairperson of the Compensation Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | +10.78% | +7.08% | +10.30% |
Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.30% | 36.23M | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics Inc. Announces Board Changes